What are Mission Vision & Core Values of Fosun Pharma Company?

What are the strategic foundations guiding Fosun Pharma's global healthcare mission?

Mission and vision statements serve as the foundational pillars of strategic direction for any thriving enterprise. These declarations articulate an organization's purpose, aspirations, and guiding principles, providing a clear compass for all business decisions and shaping its corporate identity.

For a global healthcare leader like Fosun Pharma, operating at the forefront of pharmaceutical manufacturing, research and development, distribution, medical devices, diagnostics, and healthcare services, these statements are particularly crucial. They define its commitment to addressing critical therapeutic areas such as oncology, immunology, and metabolic diseases, and guide its global presence and innovation-driven approach. Fosun Pharma's mission, vision, and values are not mere corporate platitudes but are integral to its operational framework, influencing everything from product development to market expansion and fostering a cohesive corporate culture.

As a prominent player in the healthcare industry, Fosun Pharma's strategic foundations are vital for navigating the complex global pharmaceutical landscape. In 2024, the company reported an operating revenue of RMB 41.07 billion (approximately USD 5.66 billion) and a net profit attributable to shareholders of RMB 2.77 billion (approximately USD 382 million), marking a 16.08% year-on-year increase in net profit. This financial performance underscores the importance of its strategic clarity. Furthermore, its robust R&D expenditure, totaling RMB 5.55 billion in 2024, representing 16.98% of pharmaceutical business revenue, demonstrates a strong commitment to innovation, which is deeply rooted in its core principles. These guiding statements ensure that the company's significant investments and global endeavors are aligned with its overarching purpose of creating better health for families worldwide. For a deeper understanding of its product portfolio and strategic positioning, one might consider reviewing the Fosun Pharma BCG Matrix.

Fosun Pharma remains steadfast in its mission to enable 'Better Health for Families Worldwide.' This mission is deeply integrated into its corporate strategy and daily operations. The Fosun Pharma mission statement clearly identifies the target customers as 'families worldwide,' emphasizing a broad, global scope rather than a narrow regional focus. The core service offered is 'Better Health,' which encompasses pharmaceutical products, medical devices, diagnostics, and healthcare services. The unique value proposition lies in its commitment to 'enable' this better health, suggesting an active, empowering role through innovation and accessibility.

Global Reach

The Fosun Pharma mission targets 'families worldwide,' highlighting its extensive global ambition in healthcare.

Comprehensive Health Solutions

Fosun Pharma aims to provide 'Better Health' through a wide range of products and services, including pharmaceuticals and medical devices.

Empowering Innovation

The company's commitment to 'enable' better health signifies its active role in driving healthcare innovation and accessibility.

Patient-Centric Approach

The Fosun Pharma mission is strongly customer-centric, focusing on improving patient well-being through advanced therapies.

Strategic Alignment

Fosun Pharma's mission is deeply integrated into its corporate strategy, guiding its business decisions and operations.

Impactful Contributions

The company's efforts, like malaria treatment and CAR-T cell therapy, demonstrate its tangible impact on global health.

This customer-centric and impact-focused mission is reflected in Fosun Pharma's business operations. For example, in 2024, Fosun Pharma’s independently developed artesunate for injection had saved over 80 million severe malaria patients globally, with more than 400 million doses supplied worldwide, directly manifesting its commitment to global health. Another instance is the approval of its CAR-T cell therapy product, Yi Kai Da, which has benefited over 800 lymphoma patients in mainland China by the end of 2024, showcasing its dedication to bringing advanced therapies to patients. The Fosun Pharma mission is strongly customer-centric, focusing on patient well-being, and innovation-focused, driving the development and introduction of novel treatments to achieve its health objectives. For more details on the company's journey, explore the Brief History of Fosun Pharma.

Complete Fosun Pharma Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Fosun Pharma strives to be a global leader in integrating pharmaceutical and healthcare innovations, creating better health for families worldwide. This Fosun Pharma vision is distinctly future-oriented, aiming for global leadership and emphasizing the integration of pharmaceutical and healthcare innovations. Its scope is ambitious, targeting industry disruption through integrated innovation and global impact, rather than just market leadership in specific segments. The phrase 'creating better health for families worldwide' reiterates its global and patient-centric ambition.

Global Leadership

The company aims to be a leading force in the global pharmaceutical and healthcare sectors.

Integrated Innovation

Fosun Pharma focuses on combining pharmaceutical advancements with broader healthcare solutions.

Global Health Impact

The vision emphasizes improving health outcomes for families across the globe.

Future-Oriented

The statement clearly outlines long-term aspirations and strategic direction.

Patient-Centric

A core element of the vision is dedicated to enhancing patient well-being worldwide.

Ambitious Scope

The vision targets industry disruption and broad global influence through innovation.

The realism of this Fosun Pharma vision for the future is supported by Fosun Pharma's current trajectory and market position. In 2024, Fosun Pharma's overseas revenue reached RMB 11.30 billion, accounting for 27.51% of its total revenue, demonstrating significant progress in its internationalization strategy. The company's continuous optimization of its innovative R&D system, with over 80 major pipeline projects on innovative drugs and biosimilars in 2024, further underpins its ambition to integrate and lead in healthcare innovation. Recent strategic partnerships, such as the collaboration with Teva Pharmaceutical Industries Ltd. in June 2025 to develop a novel anti-PD1-IL2 therapy in immuno-oncology, highlight its active pursuit of integrating cutting-edge innovations on a global scale. This blend of strong R&D, global expansion, and strategic collaborations suggests a realistic yet aspirational path towards its vision. This aligns with the overall Fosun Pharma business philosophy and its commitment to its Fosun Pharma mission statement.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Fosun Pharma's core values serve as the foundational principles guiding its operations and strategic decisions. These values shape the company's approach to product development, corporate culture, customer relations, and overall business practices.

The company's four core values are 'Care for life,' 'Continuous innovation,' 'Pursuit of excellence,' and 'Sustainable partnership.' These principles collectively define Fosun Pharma's identity and drive its commitment to global healthcare advancement.

Care for Life

This value underscores Fosun Pharma's deep responsibility towards human well-being, prioritizing patient safety and efficacy in product development. It fosters an ethical environment where patient outcomes are paramount, exemplified by its commitment to improving healthcare in developing countries, with its artesunate for injection having saved over 80 million severe malaria patients worldwide by the end of 2024.

Continuous Innovation

This value drives Fosun Pharma's relentless pursuit of new and improved healthcare solutions, evident in its substantial R&D investments, which totaled RMB 5.55 billion in 2024. It encourages creativity and scientific rigor, reflected in the 220 patent applications filed in 2024 for its pharmaceutical manufacturing segment.

Pursuit of Excellence

This value signifies Fosun Pharma's commitment to achieving the highest standards in all operations, ensuring stringent quality control and adherence to international standards. It promotes a performance-driven environment focused on efficiency, contributing to a 2.45 percentage point improvement in gross margin minus selling and distribution expense ratio in 2024, and a 31.13% year-on-year increase in operating cash flow to RMB 4.48 billion in 2024.

Sustainable Partnership

This value emphasizes collaborative relationships with stakeholders, including patients, healthcare professionals, and business partners. It manifests through strategic global collaborations, such as the partnership with Teva Pharmaceutical Industries Ltd. announced in June 2025, and joint ventures like the one with SVAX in Saudi Arabia in February 2025 to enhance accessibility of innovative products in the MENAT region.

These core values of Fosun Pharma are integral to its corporate culture and business philosophy, shaping its strategic vision and goals. Understanding Fosun Pharma's core values explained here provides insight into how the company defines its mission and commitment to its mission. For a broader perspective on the market, explore the Competitors Landscape of Fosun Pharma. Next, we will delve into how Fosun Pharma's mission and vision influence the company's strategic decisions.

Fosun Pharma Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

A company's mission and vision are foundational elements that shape its strategic direction and operational decisions. They provide a clear purpose and a long-term aspiration, guiding every aspect of the business from product development to market expansion.

Fosun Pharma's Guiding Principles

Fosun Pharma's mission and vision are intrinsically linked to its '4IN' strategy: Innovation, Internationalization, Intelligentization, and Integration. This framework ensures all strategic decisions are aligned with the company's overarching goal of improving global family health through integrated pharmaceutical and healthcare innovations.

• Innovation: Driving advancements in healthcare solutions.
• Internationalization: Expanding global reach and impact.
• Intelligentization: Leveraging technology for enhanced operations.
• Integration: Creating comprehensive healthcare ecosystems.

Strategic Alignment in Action

The company's commitment to innovation is evident in its substantial R&D investments. In 2024, total R&D expenditure reached RMB 5.55 billion, with pharmaceutical R&D expenses representing 16.98% of revenue. This focus directly supports the 'Continuous innovation' value and the vision of integrating healthcare innovations.

Global Expansion Driven by Vision

Fosun Pharma's internationalization strategy is a direct reflection of its mission to serve families worldwide. In 2024, overseas revenue amounted to RMB 11.30 billion, making up 27.51% of total revenue. This global footprint includes strategic partnerships across Europe, the U.S., Africa, India, and Southeast Asia.

Product Development and Market Access

The company's mission and vision influence product development, leading to the approval of 7 innovative products/biosimilars with 16 indications in 2024. Market expansion is further bolstered by collaborations, such as the joint venture in Saudi Arabia to improve product accessibility in the MENAT region and the establishment of a new sales platform in Nanning in February 2025 for Southeast Asian markets.

Strategic Acquisitions for Core Capabilities

Acquisitions, like the full acquisition of Fosun Kite (now Fosun Kairos) in September 2024, are strategic moves to strengthen its core cell therapy platform. This directly supports the innovation strategy and aims to enhance access to advanced CAR-T cell therapies.

Leadership Endorsement of Strategy

Chairman Wu Yifang emphasized the company's commitment to innovation-driven and global development strategies, including the adoption of AI and a focus on core businesses. This approach aims to enhance operational efficiency and foster predictable development.

Financial Performance Reflecting Strategic Success

Measurable outcomes demonstrate the effectiveness of this strategic alignment. In 2024, net profit attributable to shareholders increased by 16.08% year-on-year, and operating cash flow saw a 31.13% year-on-year increase, reaching RMB 4.48 billion. These financial results underscore the successful integration of the company's mission and vision into its operational framework.

These guiding principles are deeply embedded in Fosun Pharma's operations, influencing everything from R&D investments to global market expansion, ensuring a cohesive and purpose-driven approach. Continue reading to explore Core Improvements to Company's Mission and Vision.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE

Fosun Pharma's mission and vision statements serve as guiding principles for its operations and future growth. Enhancing these statements can further solidify its market position and commitment to stakeholders.

Explicitly Integrate Sustainability Commitments

While Fosun Pharma demonstrates strong ESG performance, with an MSCI ESG rating of 'A' in 2024, its mission and vision could more prominently feature sustainability. This would align with growing global expectations for environmental and social responsibility in corporate strategy.

Incorporate Digitalization and AI Focus

Given the company's active embrace of AI in its strategic outlook, explicitly mentioning 'digitalization' or 'AI-driven solutions' within its vision would better reflect current market conditions and technological advancements.

Refined Vision for Enhanced Impact

A suggested refinement for the vision could be: 'To be the global leader integrating AI-powered and sustainable pharmaceutical and healthcare innovations, creating better health for families worldwide.' This version clearly articulates a commitment to both technological advancement and responsible growth.

Strengthen Connection to Stakeholder Value

By explicitly stating commitments to sustainability and AI, Fosun Pharma can more effectively communicate its forward-thinking approach and its dedication to creating long-term value for all stakeholders, reinforcing its Revenue Streams & Business Model of Fosun Pharma.